Ono Pharmaceutical Co Stock Investor Sentiment

OPHLF Stock  USD 9.60  1.07  10.03%   
Roughly 61% of Ono Pharmaceutical's investor base is looking to short. The analysis of overall sentiment of trading Ono Pharmaceutical Co pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Ono Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Ono Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
Ono Pharmaceutical pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Ono daily returns and investor perception about the current price of Ono Pharmaceutical Co as well as its diversification or hedging effects on your existing portfolios.
  
over six months ago at news.google.com         
Ono Pharmaceutical Hits New 52-Week Low at 15.96 - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Earnings are growing at Ono Pharmaceutical but shareholders still dont like its prospects - Simply W...
Google News at Macroaxis
over six months ago at news.google.com         
Short Interest in Ono Pharmaceutical Co., Ltd. Drops By 23.8 percent - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Big News Is Coming From 3 Megabanks on April 12 4 Things Im Looking For - The Globe and Mail
Google News at Macroaxis
over six months ago at news.google.com         
Ono Pharmaceutical Co., Ltd. Short Interest Down 15.5 percent in March - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
PROSPECT Study of Tirabrutinib in RR PCNSL Completes Part A Enrollment - Targeted Oncology
Google News at Macroaxis
over six months ago at news.google.com         
Should You Buy Ono Pharmaceutical Co., Ltd. For Its Upcoming Dividend - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
KemPharm Soars on FDA Nod for ADHD Treatment, Azstarys - Yahoo News Australia
Google News at Macroaxis
over six months ago at news.google.com         
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University - Morningstar
Google News at Macroaxis
over six months ago at news.google.com         
Ono Pharmaceutical Has Announced A Dividend Of 40.00 - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Is There An Opportunity With Ono Pharmaceutical Co., Ltd.s 42 percent Undervaluation - Simply Wall S...
Google News at Macroaxis
over six months ago at news.google.com         
Ono Enters into a Research Collaboration Agreement with InveniAI to Identify Novel Therapeutic Targe...
Google News at Macroaxis
over six months ago at news.google.com         
Shattuck Labs Collaborates With Ono Pharmaceutical to Develop Fusion Proteins - Marketscreener.com
Google News at Macroaxis
over six months ago at news.google.com         
Shattuck Strikes Joint Development Deal With Japans Ono Pharma - Marketscreener.com
Google News at Macroaxis
over six months ago at news.google.com         
Transcript Strides Pharma Science Limited, Q3 2024 Earnings Call, Jan 30, 2024 - Marketscreener.com
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Ono Pharmaceutical that are available to investors today. That information is available publicly through Ono media outlets and privately through word of mouth or via Ono internal channels. However, regardless of the origin, that massive amount of Ono data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ono Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ono Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ono Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ono Pharmaceutical alpha.

Ono Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Ono Pink Sheet analysis

When running Ono Pharmaceutical's price analysis, check to measure Ono Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ono Pharmaceutical is operating at the current time. Most of Ono Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Ono Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ono Pharmaceutical's price. Additionally, you may evaluate how the addition of Ono Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Fundamental Analysis
View fundamental data based on most recent published financial statements
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories